LUMIBIRD

2020 First-quarter Revenues and Financial Position

Regulatory News:

The LUMIBIRD (Paris:LBIRD) Group, the European leader for laser technologies, is reporting 2020 first-quarter revenues of €21.9m, down 9.4%. This difference is linked primarily to the planned schedule of operations for the defense contracts, which peaked in Q1 2019 and are currently less active, while waiting for the new contracts to ramp up. The Covid-19 epidemic has also impacted revenues, but to a limited extent, as the majority of the product lines are continuing to operate.

Consolidated revenues (unaudited)

Revenues (€m)	2019	2020	Change
First quarter	24.2	21.9	-9.4%
of which
Laser	15.9	13.3	-16.5%
Medical	8.2	8.6	+4.2%

The Lumibird Group’s consolidated revenues came to €21.9m for the first quarter of 2020, down 9.4%. Like-for-like, taking into account the acquisitions of Optotek Medical and Halo Photonics, this contraction represents -16.5%.

The business shows contrasts between the Medical division, with 4.2% growth, and the Laser division (-16.5%).

For the Laser division, the contraction primarily concerns the Defense/Space business (-36% to €3.9m), marked by significantly less active schedules for operations than one year ago, as expected, on the longstanding contracts, as well as new contracts that are still starting up. The Industrial and Scientific business is virtually stable (-5.3% to €5.4m), with a similar trend seen for the Lidar business (-2.9% to €4.0m), benefiting from the inclusion of Halo Photonics, acquired in December last year, in the scope.